追踪新冠病毒感染情况：是时候做出改变了。 - Suppr

Suppr

超能文献

Tracking COVID-19 infections: time for change.

作者信息

Dean Natalie

出版信息

Nature. 2022 Feb;602(7896):185. doi: 10.1038/d41586-022-00336-8.

DOI:10.1038/d41586-022-00336-8

PMID:35136224

Abstract

摘要

相似文献

Tracking COVID-19 infections: time for change.

Nature. 2022 Feb;602(7896):185. doi: 10.1038/d41586-022-00336-8.

Optimal allocation of limited test resources for the quantification of COVID-19 infections.

Swiss Med Wkly. 2020 Dec 16;150:w20445. doi: 10.4414/smw.2020.20445. eCollection 2020 Dec 14.

Testing in the workplace: finding a path through a pandemic.

Bioanalysis. 2021 Dec;13(24):1785-1788. doi: 10.4155/bio-2021-0241. Epub 2021 Nov 18.

SARS-CoV-2 testing in travellers: Can we be smarter?

CMAJ. 2022 Jan 10;194(1):E20. doi: 10.1503/cmaj.80779.

Has COVID taught us anything about pandemic preparedness?

Nature. 2021 Aug;596(7872):332-335. doi: 10.1038/d41586-021-02217-y.

COVID-19 Laboratory Testing/CDC Guidelines.

Dis Mon. 2020 Sep;66(9):101067. doi: 10.1016/j.disamonth.2020.101067. Epub 2020 Aug 6.

Audio Interview: Covid-19 as an Endemic Disease.

N Engl J Med. 2022 Feb 10;386(6):e21. doi: 10.1056/NEJMe2201982.

Rapid COVID-19 testing: Speed, quality and cost. Can you have all three?

Clin Biochem. 2021 Sep;95:13-14. doi: 10.1016/j.clinbiochem.2021.05.009. Epub 2021 May 26.

Test, trace, and isolate in the UK.

BMJ. 2021 Mar 31;372:n822. doi: 10.1136/bmj.n822.

COVID-19: endemic doesn't mean harmless.

Nature. 2022 Jan;601(7894):485. doi: 10.1038/d41586-022-00155-x.

引用本文的文献

Prevalence of SARS-CoV-2 infection and immunity in a New York county in 2022 reveals frequent asymptomatic or undiagnosed infections.

PLoS One. 2025 May 28;20(5):e0323659. doi: 10.1371/journal.pone.0323659. eCollection 2025.

Assessment of the impacts of public health and social measures on influenza activity during the COVID-19 pandemic from 2020 to 2022 in Beijing, China: a modelling study.

BMC Infect Dis. 2025 Jan 31;25(1):150. doi: 10.1186/s12879-025-10505-5.

Political polarization and health.

Nat Med. 2024 Nov;30(11):3085-3093. doi: 10.1038/s41591-024-03307-w. Epub 2024 Oct 25.

Inferring community transmission of SARS-CoV-2 in the United Kingdom using the ONS COVID-19 Infection Survey.

Infect Dis Model. 2024 Jan 30;9(2):299-313. doi: 10.1016/j.idm.2024.01.011. eCollection 2024 Jun.

Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.

Emerg Infect Dis. 2024 Feb;30(2). doi: 10.3201/eid3002.230768. Epub 2024 Jan 8.

Designing Surveillance at a Population Level.

Am J Public Health. 2023 Nov;113(11):1143-1145. doi: 10.2105/AJPH.2023.307425. Epub 2023 Sep 21.

"Boosting" Surveillance for a More Impactful Public Health Response During Protracted and Evolving Infectious Disease Threats: Insights From the COVID-19 Pandemic.

Health Secur. 2023 Sep;21(S1):S47-S55. doi: 10.1089/hs.2023.0046. Epub 2023 Aug 29.

A Design and Analytical Strategy for Monitoring Disease Positivity and Biomarker Levels in Accessible Closed Populations.

Am J Epidemiol. 2024 Jan 8;193(1):193-202. doi: 10.1093/aje/kwad177.

Prioritizing non-communicable diseases in the post-pandemic era based on a comprehensive analysis of the GBD 2019 from 1990 to 2019.

Sci Rep. 2023 Aug 16;13(1):13325. doi: 10.1038/s41598-023-40595-7.

Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England.

Nat Commun. 2023 Jul 17;14(1):4279. doi: 10.1038/s41467-023-39661-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验